Eudaimonia Advisors’s Ralph Lauren RL Stock Holding History

Eudaimonia Advisors’s Portfolio RL Stock Details RL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$306K	Buy	1,631 +1	+0.1%	+$165	0.16%	127
2023 Q4	$235K	Buy	+1,630	New	+$202K	0.15%	138
2023 Q3	–	Sell	-1,627	Closed	-$201K	–	148
2023 Q2	$201K	Buy	+1,627	New	+$188K	0.13%	143

Other funds holding RL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Eudaimonia Advisors's RL Position: Q1 2024 in Review

Eudaimonia Advisors increased its Ralph Lauren (RL) stake by 0.06% in Q1 2024, buying an estimated $165 and bringing the position to 1,631 shares worth $306K. The position accounts for 0.16% of the portfolio, ranked #127.

Eudaimonia Advisors first reported a position in RL in Q2 2023 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold RL as of Q1 2024.

Eudaimonia Advisors held 1,631 shares of Ralph Lauren worth $306K as of Q1 2024.
Eudaimonia Advisors bought 1 Ralph Lauren share in Q1 2024, an estimated $165.
Ralph Lauren made up 0.16% of Eudaimonia Advisors's portfolio in Q1 2024, its #127 holding.
Eudaimonia Advisors first reported a position in Ralph Lauren in Q2 2023 and has held it in 3 quarters since.
498 funds tracked by Wall St. Rank held Ralph Lauren as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.